B careful: Humoral responses and COVID-19 severity.

Fanous, Hani; Guerrero-Pena, Angela; Pillai, Asha

Fanous, Hani; Guerrero-Pena, Angela; Pillai, Asha.

Fanous H; Department of Pediatrics, University of Miami School of Medicine, Miami, FL, USA.
Guerrero-Pena A; Department of Pediatrics, University of Miami School of Medicine, Miami, FL, USA.
Pillai A; Department of Pediatrics, University of Miami School of Medicine, Miami, FL, USA. asha.pillai@med.miami.edu.

Sci Immunol ; 5(54)2020 12 04.

Article in English | MEDLINE | ID: covidwho-961006

ABSTRACT

ABSTRACT

Neutralizing antibody responses to SARS-CoV-2, though often of limited longevity, have generally been assumed to be protective against COVID-19 disease.

Subject(s)

Antibodies, Neutralizing/immunology; Antibodies, Viral/immunology; COVID-19/immunology; Immunity, Humoral; SARS-CoV-2/immunology; Antibodies, Neutralizing/blood; Antibodies, Viral/blood; B-Lymphocytes/immunology; B-Lymphocytes/virology; C-Reactive Protein/immunology; COVID-19/epidemiology; COVID-19/virology; Humans; Pandemics; SARS-CoV-2/physiology; Severity of Illness Index

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Antibodies, Neutralizing / Immunity, Humoral / SARS-CoV-2 / COVID-19 / Antibodies, Viral Type of study: Observational study / Prognostic study Limits: Humans Language: English Year: 2020 Document Type: Article Affiliation country: Sciimmunol.abf8870

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google